| Company Name: | Natural Health Trends Corporation | | Ticker Symbol: | BHIP | | | WWW Address: | www.naturalhealthtrendscorp.com | | CEO: | Chris T. Sharng | | No. of Employees: | 136 | | Common Issue Type: | CS | | Business Description: | An international direct-selling and e-commerce company, which offers a line of 'NHT Global' branded products.
|
| | | Industry Information: | CONSUMER NON-DURABLES - Personal Products [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 0.24 |  0.03 | 0.2 | 0.41 | 0.22 | 0.35 | 0.30 | 5500 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 3.8 | 10.7 | 2.09 | -0.40 | 0.00 | 0.0 | 0.0 | 1.06 - 0.21 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 0.35 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 3.8 | mil |
| Latest Shares Outstanding | 10.7 | mil |
| Earnings pS (EPS) | -0.40 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 336,809 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 8.6 | mil |
| Float as % of Shares Outstanding | 79.7 | % |
| Foreign Sales | 43 | mil |
| Domestic Sales | 3 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 79.00 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 72.9 | % |
| EBITDA Margin | -6.1 | % |
| Pre-Tax Profit Margin | -14.4 | % |
| Assets Turnover | 2.4 | % |
| Return on Assets (ROA) | -46.5 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -309.9 | % |
| Current Ratio | 0.7 | |
| Leverage Ratio (Assets/Equity) | 7.1 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.99 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | -0.34 | $ |
| Cash pS | 0.47 | $ |
| Book-Value pS | 0.17 | $ |
| Tangible Book-Value pS | -0.12 | $ |
| Cash Flow pS | -0.40 | $ |
| Free Cash Flow pS | -0.19 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.01 | |
| Price/Tangible Book Ratio | -2.93 | |
| Price/Cash Flow | -0.9 | |
| Price/Free Cash Flow | -1.9 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -25.9 | 72 | 451 | 4,075 |
| 4 Weeks | 0.60 | 0.30 | 0.53 | -33.6 | 66 | 292 | 5,265 |
| 13 Weeks | 1.06 | 0.30 | 0.88 | -60.0 | 37 | 342 | 21,226 |
| 26 Weeks | 1.06 | 0.30 | 0.44 | -20.0 | 64 | 239 | 29,912 |
| 52 Weeks | 1.06 | 0.21 | 0.38 | -7.4 | 74 | 188 | 46,842 |
| YTD | 1.06 | 0.21 | - | 17.3 | 96 | 192 | 41,860 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 0.43 | 0.45 | 0.54 | 0.59 | 0.51 | 2.09 | 2.35 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -20.55 | 59.6 | -34.61 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 0.00 | NA | 0.00 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -22.7 | -31.3 | -40.1 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | -0.22 | -0.12 | 2.75 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | -24.43 |
| Current Ratio | 0.6 |
| Quick Ratio (Acid Test) | 0.3 |
| Liquidity Ratio (Cash) | 0.35 |
| Receivables Turnover | 187.3 |
| Average Collection Period | 2 |
| Working Capital/Equity | -72.2 |
| Working Capital pS | -0.38 |
| Cash-Flow pS | -0.19 |
| Free Cash-Flow pS | -0.28 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 2.19 |
| Financial Leverage Ratio (Assets/Equity) | 3.0 |
| Debt Ratio | 65.4 |
| Total Debt/Equity (Gearing Ratio) | 0.27 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 0.6 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 41.89 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.66 |
| Tobin's Q Ratio | 0.23 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | -8.18 |
| Enterprise Value (EV)/Free Cash Flow | -15.15 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -2.93 |
| Price/Book Ratio - LTM | 2.01 |
| Price/Cash Flow Ratio | -0.9 |
| Price/Free Cash Flow Ratio - LTM | -1.9 |
| Price/Sales Ratio | 0.09 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 1.01 |
| Tangible Book Value pS - LTM | -0.12 |
| Book Value pS - LTM | 0.17 |
| Capital Invested pS | 0.54 |
| Cash pS - LTM | 0.47 |
| Cash Flow pS - LTM | -0.40 |
| Free Cash Flow pS - LTM | -0.19 |
| Earnings pS (EPS) | -0.40 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -6.61 |
| Free Cash Flow Margin 5YEAR AVG | -5.98 |
| Net Profit Margin | -8.4 |
| Net Profit Margin - 5YEAR AVRG. | -7.7 |
| Equity Productivity | 8.14 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 7.96 |
| Return on Capital Invested (ROCI) | -67.2 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -38.7 |
| Assets Productivity | 2.20 |
| Return on Assets (ROA) | -23.2 |
| Return on Assets (ROA) - 5YEAR AVRG. | -20.8 |
| Gross Profit Margin | 72.9 |
| Gross Profit Margin - 5YEAR AVRG. | 77.2 |
| EBITDA Margin - LTM | -6.1 |
| EBIT Margin - LTM | -6.1 |
| Pre-Tax Profit Margin | -7.4 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -7.1 |
| Effective Tax Rate | -13.4 |
| Effective Tax Rate - 5YEAR AVRG. | -5.5 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 85 |
| Revenue per Employee | 336,809 |
| Net Income per Employee | -28,412 |
| Average Collection Period | 1 |
| Receivables Turnover | 187.3 |
| Day's Inventory Turnover Ratio | 84 |
| Inventory Turnover | 4.3 |
| Inventory/Sales | 4.7 |
| Accounts Payble/Sales | 3.81 |
| Assets/Revenue | 0.45 |
| Net Working Capital Turnover | -11.28 |
| Fixed Assets Turnover | 4.65 |
| Total Assets Turnover | 2.2 |
| Revenue per $ Cash | 13.12 |
| Revenue per $ Plant | 39.05 |
| Revenue per $ Common Equity | 8.14 |
| Revenue per $ Capital Invested | 7.96 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 76.0 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 81.1 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |